Author:
Baumann Philipp,Mandl-Weber Sonja,Oduncu Fuat,Schmidmaier Ralf
Subject
Cancer Research,Oncology,Hematology
Reference8 articles.
1. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells;Hideshima;Cancer Res,2001
2. Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341;Hideshima;Blood,2003
3. The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents;Ma;Clin Cancer Res,2003
4. The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications;Mitsiades;Blood,2003
5. Phase I/II trial assessing bortezomib and melphalan combination therapy for the treatment of patients with relapsed or refractory multiple myeloma;Berenson;J Clin Oncol,2006
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献